Abstract

Dr. Sanjivani Tukaram Hambarde* and Dr. Pravin Dadarao Kadam

ABSTRACT

The aim of study was clinical, antibacterial evaluation of efficacy of Mustadi Yog in the children suffering from kasa. For clinical study 06 children of the age group of 5 year to 15 years were selected after evaluating them clinically for Respiratory allergic disorders RADs as per the inclusion criteria, from O.P.D. and I.P.D. of PG Department Kaumarabhritya, divided into two groups, group A (Trial group) received Mustadi Yog I and Group B (Control group) received Salbutamol in syrup duration of study was 14 days. Assessment was done using four point severity scale of clinical symptoms and laboratory assessment through Peak flow expiratory rate (PEFR), Blood investigations (Hb%, TLC, DLC, TEC) and good result in group A patient, treated with Syrup Mustadi Yog I. In itching of nose and eyes, highly significant improvement was seen in group A. On the other hand in group B all the outcomes were insignificant. The study drug Mustadi Yog I is effective in alleviating and reducing the morbidity score in Respiratory allergic disorders as compared to the previous morbidity history.[1]